尼古丁对健康非吸烟者威胁回避行为的影响。

IF 3.5 3区 医学 Q2 NEUROSCIENCES
Madeleine Mueller, Christoph Korn, Jan Haaker
{"title":"尼古丁对健康非吸烟者威胁回避行为的影响。","authors":"Madeleine Mueller, Christoph Korn, Jan Haaker","doi":"10.1007/s00213-025-06789-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Developing adaptive strategies for survival relies on distinguishing danger from safety through aversive learning mechanisms. Chronic and acute nicotine exposure have been linked to impaired aversive learning and reduced discrimination between threat and safety. Yet, it is unclear if nicotine also impacts one behavioural consequence of aversive learning, which is the avoidance of threats.</p><p><strong>Objectives: </strong>This preregistered study examines how acute nicotine influences costly avoidance behaviour in non-smokers.</p><p><strong>Methods: </strong>To this end, healthy non-smoking participants (n = 66) received either 1 mg nicotine or a placebo in a double-blind design and underwent an active avoidance task. During acquisition, participants could choose between a safer but longer path to reach their goal or a shorter path (less effort) with a higher chance of receiving an aversive outcome in the form of an electrical stimulus. During uninstructed extinction, both paths no longer contained the risk of an aversive outcome and participants could learn this new safety association by trial and error. Finally, an instructed extinction phase indicated complete safety.</p><p><strong>Results: </strong>Contrary to our pre-registered hypotheses, participants with nicotine intake showed a trendwise reduced avoidance of aversive outcomes, compared to placebo controls. Further analysis revealed however that nicotine did not enhance safety learning during extinction in the nicotine group, as compared to controls.</p><p><strong>Conclusions: </strong>In conclusion, this study strengthens the evidence that nicotine alters learning to identify threat and safety, which is also transferred to avoidance behaviour.</p>","PeriodicalId":20783,"journal":{"name":"Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The effect of nicotine on threat avoidance behaviour in healthy non-smokers.\",\"authors\":\"Madeleine Mueller, Christoph Korn, Jan Haaker\",\"doi\":\"10.1007/s00213-025-06789-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Rationale: </strong>Developing adaptive strategies for survival relies on distinguishing danger from safety through aversive learning mechanisms. Chronic and acute nicotine exposure have been linked to impaired aversive learning and reduced discrimination between threat and safety. Yet, it is unclear if nicotine also impacts one behavioural consequence of aversive learning, which is the avoidance of threats.</p><p><strong>Objectives: </strong>This preregistered study examines how acute nicotine influences costly avoidance behaviour in non-smokers.</p><p><strong>Methods: </strong>To this end, healthy non-smoking participants (n = 66) received either 1 mg nicotine or a placebo in a double-blind design and underwent an active avoidance task. During acquisition, participants could choose between a safer but longer path to reach their goal or a shorter path (less effort) with a higher chance of receiving an aversive outcome in the form of an electrical stimulus. During uninstructed extinction, both paths no longer contained the risk of an aversive outcome and participants could learn this new safety association by trial and error. Finally, an instructed extinction phase indicated complete safety.</p><p><strong>Results: </strong>Contrary to our pre-registered hypotheses, participants with nicotine intake showed a trendwise reduced avoidance of aversive outcomes, compared to placebo controls. Further analysis revealed however that nicotine did not enhance safety learning during extinction in the nicotine group, as compared to controls.</p><p><strong>Conclusions: </strong>In conclusion, this study strengthens the evidence that nicotine alters learning to identify threat and safety, which is also transferred to avoidance behaviour.</p>\",\"PeriodicalId\":20783,\"journal\":{\"name\":\"Psychopharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00213-025-06789-9\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00213-025-06789-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

理论基础:发展适应生存策略依赖于通过厌恶学习机制区分危险和安全。慢性和急性尼古丁暴露与受损的厌恶学习和减少威胁和安全之间的区别有关。然而,目前尚不清楚尼古丁是否也会影响厌恶学习的一种行为后果,即避免威胁。目的:本预注册研究探讨急性尼古丁如何影响非吸烟者的昂贵的避免行为。方法:为此,健康的非吸烟参与者(n = 66)在双盲设计中接受1mg尼古丁或安慰剂,并进行主动回避任务。在获取过程中,参与者可以选择一条更安全但更长的路径来达到他们的目标,或者一条更短的路径(更少的努力),但更有可能收到以电刺激形式出现的厌恶结果。在非指示消失过程中,两种路径都不再包含厌恶结果的风险,参与者可以通过试验和错误来学习这种新的安全关联。最后,指示熄灭阶段表明完全安全。结果:与我们预先登记的假设相反,与安慰剂对照组相比,尼古丁摄入量的参与者对厌恶结果的回避呈趋势减少。然而,进一步的分析显示,与对照组相比,尼古丁组在灭绝期间并没有增强安全学习。结论:总之,这项研究加强了尼古丁改变学习识别威胁和安全的证据,这也转移到回避行为。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The effect of nicotine on threat avoidance behaviour in healthy non-smokers.

Rationale: Developing adaptive strategies for survival relies on distinguishing danger from safety through aversive learning mechanisms. Chronic and acute nicotine exposure have been linked to impaired aversive learning and reduced discrimination between threat and safety. Yet, it is unclear if nicotine also impacts one behavioural consequence of aversive learning, which is the avoidance of threats.

Objectives: This preregistered study examines how acute nicotine influences costly avoidance behaviour in non-smokers.

Methods: To this end, healthy non-smoking participants (n = 66) received either 1 mg nicotine or a placebo in a double-blind design and underwent an active avoidance task. During acquisition, participants could choose between a safer but longer path to reach their goal or a shorter path (less effort) with a higher chance of receiving an aversive outcome in the form of an electrical stimulus. During uninstructed extinction, both paths no longer contained the risk of an aversive outcome and participants could learn this new safety association by trial and error. Finally, an instructed extinction phase indicated complete safety.

Results: Contrary to our pre-registered hypotheses, participants with nicotine intake showed a trendwise reduced avoidance of aversive outcomes, compared to placebo controls. Further analysis revealed however that nicotine did not enhance safety learning during extinction in the nicotine group, as compared to controls.

Conclusions: In conclusion, this study strengthens the evidence that nicotine alters learning to identify threat and safety, which is also transferred to avoidance behaviour.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Psychopharmacology
Psychopharmacology 医学-精神病学
CiteScore
7.10
自引率
5.90%
发文量
257
审稿时长
2-4 weeks
期刊介绍: Official Journal of the European Behavioural Pharmacology Society (EBPS) Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields: Human Psychopharmacology: Experimental This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered. Human Psychopharmacology: Clinical and Translational This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects. Preclinical psychopharmacology: Behavioral and Neural This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels. Preclinical Psychopharmacology: Translational This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways. Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信